Drug Manufacturers - Specialty & Generic · Healthcare
Todd Anthony
Equibles does not estimate personal net worth.
Get an email with a short summary when Cumberland Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get CPIX alertsAbout Todd Anthony
Cumberland Pharmaceuticals Inc reported in an 8-K filed March 15, 2023 that Todd Anthony was appointed Vice President of Organizational Development, effective January 1, 2023. The proxy statement of Cumberland Pharmaceuticals Inc reports total compensation of $355,605 for Todd Anthony in fiscal 2025, including a base salary of $297,570. Disclosed compensation is on record for 3 fiscal years. Todd Anthony has spoken on 3 earnings calls across 1 company, most recently for Cumberland Pharmaceuticals Inc on August 4, 2026. Cumberland Pharmaceuticals Inc is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Cumberland Pharmaceuticals Inc includes Caroline R. Young (Board Member), Joey A. Jacobs (Board Member), Jonathan I. Griggs (Board Member) and 2 others.
“In consideration of your appointment as Vice President of Organizational Development the Company, and other good and valuable consideration, the receipt and sufficiency of which is hereby acknowledged, the parties agree as follows:”
Todd Anthony on recent calls
“Well, as previously noted, our key development programs are based on our first new chemical entity, efitriban. It's a potent and selective thromboxane receptor antagonist that has now been administered to approximately 1,400 subjects across multiple clinical studies, demonstrating a strong safety profile.”
Affiliation history
-
Cumberland Pharmaceuticals Inc (CPIX)
Source not stated
Current
Company network
Leadership on record at Cumberland Pharmaceuticals Inc
- Caroline R. Young Board Member
- Joey A. Jacobs Board Member
- Jonathan I. Griggs Board Member
- Kenneth J. Krogulski Board Member
- Martin S. Brown Jr Board Member
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2025 | Cumberland Pharmaceuticals Inc (CPIX) | — | $297,570 | $355,605 |
| 2024 | Cumberland Pharmaceuticals Inc (CPIX) | — | $286,125 | $323,752 |
| 2023 | Cumberland Pharmaceuticals Inc (CPIX) | — | $272,500 | $330,852 |